Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (221-230 of 306) with videos related to

Pageof 31
Sort By:
Journal of Gastroenterology|August 10, 2013
Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudineFumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 27, 2019
Real-world effects of long-term rifaximin treatment for Japanese patients with hepatic encephalopathyHiroyuki Suzuki, Hitomi Sezaki, Fumitaka Suzuki, et al.
Digestive Diseases and Sciences|January 23, 2010
Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitisYoshiyuki Suzuki, Kenji Ikeda, Miharu Hirakawa, et al.
Journal of Medical Virology|August 21, 2007
Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudineMariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Clinics and Research in Hepatology and Gastroenterology|September 9, 2021
Clinicopathological assessment of steatohepatitic hepatocellular carcinomaKenji Yamaoka, Satoshi Saitoh, Keiichi Kinowaki, et al.
Journal of Gastroenterology|February 10, 2004
Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudineMarie Matsuda, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2009
Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatmentMariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Oncology|April 28, 2017
Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver DiseaseFumihiro Ogata, Masahiro Kobayashi, Norio Akuta, et al.
Internal Medicine (Tokyo, Japan)|November 5, 2008
Natural human interferon beta plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus and a high viral loadYoshio Katamura, Fumitaka Suzuki, Norio Akuta, et al.
Journal of Medical Virology|March 26, 2004
Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis BAkihito Tsubota, Yasuji Arase, Fumitaka Suzuki, et al.
Pageof 31

Showing results (221-230 of 306) with videos related to

Sort By:
Pageof 31
Journal of Gastroenterology|August 10, 2013
Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudineFumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 27, 2019
Real-world effects of long-term rifaximin treatment for Japanese patients with hepatic encephalopathyHiroyuki Suzuki, Hitomi Sezaki, Fumitaka Suzuki, et al.
Digestive Diseases and Sciences|January 23, 2010
Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitisYoshiyuki Suzuki, Kenji Ikeda, Miharu Hirakawa, et al.
Journal of Medical Virology|August 21, 2007
Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudineMariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Clinics and Research in Hepatology and Gastroenterology|September 9, 2021
Clinicopathological assessment of steatohepatitic hepatocellular carcinomaKenji Yamaoka, Satoshi Saitoh, Keiichi Kinowaki, et al.
Journal of Gastroenterology|February 10, 2004
Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudineMarie Matsuda, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2009
Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatmentMariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Oncology|April 28, 2017
Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver DiseaseFumihiro Ogata, Masahiro Kobayashi, Norio Akuta, et al.
Internal Medicine (Tokyo, Japan)|November 5, 2008
Natural human interferon beta plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus and a high viral loadYoshio Katamura, Fumitaka Suzuki, Norio Akuta, et al.
Journal of Medical Virology|March 26, 2004
Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis BAkihito Tsubota, Yasuji Arase, Fumitaka Suzuki, et al.
Pageof 31